KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Share-based Compensation: 2010-2024

Historic Share-based Compensation for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $264,000.

  • TherapeuticsMD's Share-based Compensation fell 98.96% to $1,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $81,000, marking a year-over-year decrease of 85.46%. This contributed to the annual value of $264,000 for FY2024, which is 79.23% down from last year.
  • Per TherapeuticsMD's latest filing, its Share-based Compensation stood at $264,000 for FY2024, which was down 79.23% from $1.3 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Share-based Compensation registered a high of $18.1 million during FY2021, and its lowest value of $264,000 during FY2024.
  • Its 3-year average for Share-based Compensation is $4.4 million, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, TherapeuticsMD's Share-based Compensation surged by 69.39% in 2021 and then plummeted by 89.04% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Share-based Compensation stood at $10.7 million in 2020, then spiked by 69.39% to $18.1 million in 2021, then tumbled by 36.00% to $11.6 million in 2022, then plummeted by 89.04% to $1.3 million in 2023, then crashed by 79.23% to $264,000 in 2024.